Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03907462 · ClinicalTrials.gov registry record · NA
SMART 2.0: Social Mobile Approaches to Reducing weighT in Young Adults
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 638
- Enrollment target
NCT03907462: Completed NA study, sponsored by University of California, San Diego.
NCT03907462 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 638 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03907462, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 638 participants
- Enrollment target
Study Summary
The SMART 2.0 study is a 24-month trial designed to evaluate the impact of the intervention with technology and personal health coaching or with technology alone on objectively measured weight among overweight young adults in a university setting over 24 months compared to a control group. The investigators hypothesize that both interventions will significantly improve weight compared to the control group, and the group receiving personal health coaching will experience the greatest improvement.
Primary Outcome
Objectively measured weight in kilograms.
Interventions
- BEHAVIORAL SMART 2.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 638 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
What the finished NCT03907462 record still lists
NCT03907462 is an interventional study that assigns participants to a tested intervention. The registered 638 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which SMART 2.0 is the first listed.
NCT03907462 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03907462 about?
NCT03907462 is a clinical study titled "SMART 2.0: Social Mobile Approaches to Reducing weighT in Young Adults". The SMART 2.0 study is a 24-month trial designed to evaluate the impact of the intervention with technology and personal health coaching or with technology alone on objectively measured weight among overweight young adults in a university setting over 24 months compared to a control group. The inves...
What is the current status of trial NCT03907462?
This trial is currently completed. It is a NA study. The enrollment target is 638 participants. The study started on 2019-04-01. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT03907462?
The interventions under investigation include: SMART 2.0 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03907462?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03907462's enrollment target sits among peer trials
638 157th of 2000 higher than 1,844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI